World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
146
Citations
117598
World Ranking
1313
National Ranking
757

Overview

David J. Cohen is affiliated with the University of Missouri-Kansas City in the United States. Their research contributions fall predominantly within the field of Medicine, with a strong emphasis on Cardiology and Cardiovascular Medicine. Other areas of their work include Surgery, Epidemiology, Radiology, Nuclear Medicine and Imaging, as well as Pulmonary and Respiratory Medicine.

Their research covers various topics with a focus on cardiovascular health and treatments. Key subjects include:

  • Cardiac Valve Diseases and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Coronary Interventions and Diagnostics
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac, Anesthesia and Surgical Outcomes

They have frequently published in the following venues:

  • Journal of the American College of Cardiology
  • JACC: Cardiovascular Interventions
  • Circulation
  • Circulation Cardiovascular Interventions
  • Circulation Cardiovascular Quality and Outcomes

Some of their recent papers include:

  • "Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research," 2021, Journal of the American College of Cardiology
  • "STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement," 2020, Journal of the American College of Cardiology
  • "Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement," 2020, New England Journal of Medicine
  • "Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research," 2020, European Heart Journal
  • "Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years," 2023, New England Journal of Medicine

David J. Cohen has collaborated extensively with several coauthors, including:

  • Michael J. Mack
  • Martin B. Leon
  • Suzanne V. Arnold
  • Vinod H. Thourani
  • Samir Kapadia

Best Publications

  • Clinical End Points in Coronary Stent Trials A Case for Standardized Definitions

    Donald E. Cutlip;Stephan Windecker;Roxana Mehran;Ashley Boam

  • Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

    A. Pieter Kappetein;Stuart J. Head;Philippe Généreux;Nicolo Piazza

  • Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke

    Jeffrey L. Saver;Mayank Goyal;Alain Bonafe;Hans Christoph Diener

  • Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.

    Martin B Leon;Craig R. Smith;Michael J. Mack;Michael J. Mack;Rajendra Makkar

  • Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients

    Michael J. Mack;Martin B. Leon;Vinod H. Thourani;Raj Makkar

  • Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis

    Thomas G. Brott;Thomas G. Brott;Robert W. Hobson;George Howard;Gary S. Roubin

  • Transcatheter Mitral-Valve Repair in Patients with Heart Failure.

    Gregg W. Stone;JoAnn Lindenfeld;William T. Abraham;Saibal Kar

  • Strategies for Multivessel Revascularization in Patients with Diabetes

    Michael E. Farkouh;Michael Domanski;Lynn A. Sleeper;Flora S. Siami

  • Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

    Laura Mauri;Dean J. Kereiakes;Robert W. Yeh;Priscilla Driscoll-Shempp

  • Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

    C.M. Legendre;C. Licht;P. Muus;L.A. Greenbaum

  • Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: REPLACE-2 Randomized Trial

    A. Michael Lincoff;John A. Bittl;Robert A. Harrington;Frederick Feit

  • State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3.

    Uwe Siebert;Uwe Siebert;Oguzhan Alagoz;Ahmed M. Bayoumi;Beate Jahn

  • Stent Thrombosis in the Modern Era A Pooled Analysis of Multicenter Coronary Stent Clinical Trials

    Donald E. Cutlip;Donald S. Baim;Kalon K. L. Ho;Jeffrey J. Popma

  • Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research.

    Philippe Généreux;Nicolo Piazza;Maria C. Alu

  • Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement: Results From the PREMIER Registry

    John A. Spertus;Richard Kettelkamp;Clifton Vance;Carole Decker

  • Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis

    Vinod H. Thourani;Susheel Kodali;Raj R. Makkar;Howard C. Herrmann

  • Stenting and medical therapy for atherosclerotic renal-artery stenosis

    Christopher J. Cooper;Timothy P. Murphy;Donald E. Cutlip;Kenneth Jamerson

  • Dual Action of Neutrophil Gelatinase–Associated Lipocalin

    Kai M. Schmidt-Ott;Kiyoshi Mori;Jau Yi Li;Avtandil Kalandadze

  • Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

    Robert W. Yeh;Robert W. Yeh;Eric A. Secemsky;Dean J. Kereiakes;Sharon-Lise T. Normand

  • Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.

    E J Topol;D J Moliterno;H C Herrmann;E R Powers

Frequent Co-Authors

John A. Spertus
John A. Spertus University of Missouri–Kansas City
Donald E. Cutlip
Donald E. Cutlip Beth Israel Deaconess Medical Center
Richard E. Kuntz
Richard E. Kuntz Brigham and Women's Hospital
Matthew R. Reynolds
Matthew R. Reynolds Tufts University
Michael J. Mack
Michael J. Mack Scott & White Memorial Hospital
Roxana Mehran
Roxana Mehran Icahn School of Medicine at Mount Sinai
Laura Mauri
Laura Mauri University of Milan
Donald S. Baim
Donald S. Baim Harvard University
Eric D. Peterson
Eric D. Peterson The University of Texas Southwestern Medical Center
C. Michael Gibson
C. Michael Gibson Beth Israel Deaconess Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees provides a flexible route for those interested in the medical field but not pursuing traditional MD programs. For example, many students start their careers with lpn online programs, which offer a streamlined path to become a Licensed Practical Nurse. These programs are ideal for those seeking swift entry into patient care.

For those aiming for advanced practice roles, pmhnp online programs can prepare graduates to serve as Psychiatric Mental Health Nurse Practitioners, a highly in-demand specialty. These programs emphasize mental health assessment and care, offering a vital service to communities.

If your interests lean toward healthcare leadership rather than direct patient care, consider pursuing administrative degrees. The cheapest mha programs online allow students to gain crucial management skills while balancing work and study. This can be further explored with the cheapest mha programs online healthcare options, which provide affordable pathways to a Master’s in Healthcare Administration.

Each of these online programs offers flexibility, cost savings, and new career opportunities within the U.S. healthcare system.

Best Scientists Citing David J. Cohen

Trending Scientists

Recently Published Articles